By Saminu Ibrahim
The World Health Organisation (WHO) has called on African governments to intensify efforts to combat antimicrobial resistance (AMR), warning that the growing threat is undermining the effectiveness of medicines and putting millions of lives at risk.
WHO Regional Director for Africa, Dr Mohamed Janabi, made the call in a message marking the 2026 World Antimicrobial Resistance Awareness Week, observed from November 18 to 24, under the theme, “One Health, One Action: Prevent AMR Now”.
Janabi said antimicrobial resistance occurs when bacteria, viruses, fungi and parasites no longer respond to medicines, making infections increasingly difficult to treat.
He noted that bacterial antimicrobial resistance was associated with an estimated 4.7 million deaths globally in 2021, with sub-Saharan Africa recording the highest rates of AMR-associated mortality.
According to him, the discovery of penicillin and other antibiotics transformed modern medicine by making previously fatal infections treatable and improving the safety of surgical procedures, cancer treatment and organ transplants.
However, he warned that the effectiveness of medicines relied upon for generations was declining, threatening these medical advances and placing additional pressure on families and healthcare systems.
The WHO regional director identified inappropriate use of antimicrobials in humans and animals, poor infection prevention practices, inadequate water and sanitation facilities, and unsafe waste disposal as major factors accelerating the spread of resistance.
He stressed that tackling the challenge required coordinated action across human health, animal health, agriculture and the environment, in line with the One Health approach.
Janabi said countries in the WHO African Region had recorded progress in addressing AMR, noting that all 47 member states had developed national action plans, although the level of implementation varied.
He added that all 47 countries were enrolled in WHO’s Global Antimicrobial Resistance and Use Surveillance System, while 44 had the capacity to conduct susceptibility testing for priority bacterial pathogens.
He further disclosed that 36 countries had adopted WHO’s Access, Watch and Reserve classification of antibiotics to promote responsible prescribing and support the global target of ensuring that at least 70 per cent of antibiotics used in human healthcare come from the Access group by 2030.
On regional coordination, Janabi said the number of countries with functional One Health AMR governance mechanisms increased from 15 in 2023 to 29 in 2026.
He commended member states and WHO’s regional Quadripartite partners, comprising the Food and Agriculture Organisation of the United Nations, the United Nations Environment Programme and the World Organisation for Animal Health, for their collaboration.
The WHO official, however, urged governments to translate existing national action plans into adequately funded programmes with clear responsibilities and measurable outcomes.
He called for increased domestic investment in laboratories, surveillance systems and responsible antimicrobial use, while ensuring that people have access to quality-assured medicines and appropriate treatment.
Janabi also urged health professionals, animal health workers and agricultural practitioners to strengthen infection prevention measures and ensure the responsible use of antimicrobials.
He called on researchers, industry players and development partners to support national priorities, improve equitable access to diagnostic services and treatment, and strengthen evidence-based interventions.
The regional director further encouraged communities, young people, educators and the media to promote public awareness of antimicrobial resistance.
He advised members of the public to keep vaccinations up to date, practise proper hand hygiene, use antibiotics only when prescribed by qualified health professionals and avoid sharing leftover medicines.
He said WHO would continue working with governments and partners to strengthen the One Health response and safeguard the effectiveness of medicines essential to modern healthcare.
“AMR is everyone’s business,” Janabi said, urging individuals to adopt at least one practical measure during the awareness week and sustain the commitment throughout the year.
He emphasised that collective action was necessary to ensure that life-saving medicines remained effective for present and future generations.